Muscle protein metabolism in finishing pigs fed ractopamine.
Forty crossbred barrows (average initial weight, 66.4 kg) were utilized to determine the effects of ractopamine (a phenethanolamine/beta adrenergic agonist) on protein accretion and synthesis, activities of cathepsins B, H, L and calcium-dependent proteinase and nucleic acid content of semitendinosus muscle (ST). All pigs were offered a 16% protein, mineral and vitamin fortified corn-soybean meal diet supplemented with either 0 or 20 ppm ractopamine for 14, 21, 28, 35 or 42 d. Protein synthesis (fractional rates) was studied in pigs at d 21 and 35; ST protease activities, protein and nucleic acid content were measured on d 14, 28 and 42. Ractopamine increased (P less than .01) ST total protein content and maintained RNA muscle concentration and total ST muscle RNA content. DNA content (mg/g ST) declined (P less than .05) upon ractopamine feeding, but total DNA per muscle remained unchanged except for d 42, when the ST muscles were largest. Fractional accretion rates (FAR) were 1.0 and 1.2% for control and ractopamine-fed pigs, respectively. Fractional protein synthesis rate (FSR) was higher (P less than .06) in ractopamine-fed pigs (6.1%/d) than in control pigs (4.4%/d). Fractional protein synthesis rate could account for the observed muscle hypertrophy and increased FAR. Estimated fractional breakdown rates (FBR = FSR - FAR) were 3.4%/d and 4.9%/d for control and ractopamine-fed pigs, respectively. The activities of the catheptic proteases and calcium-dependent proteinase were not affected by the treatments.
Bergen
W G
WG
Michigan State University, East Lansing 48824.
Johnson
S E
SE
Skjaerlund
D M
DM
Babiker
A S
AS
Ames
N K
NK
Merkel
R A
RA
Anderson
D B
DB
D000318:Adrenergic beta-Agonists / Q000494:pharmacology*; D000818:Animals; D002403:Cathepsins / Q000032:analysis; D004247:DNA / Q000032:analysis; D008297:Male; D024510:Muscle Development; D009124:Muscle Proteins / Q000032:analysis / Q000096:biosynthesis / Q000378:metabolism*; D009132:Muscles / Q000187:drug effects* / Q000201:enzymology / Q000378:metabolism; D009929:Organ Size / Q000187:drug effects; D010447:Peptide Hydrolases / Q000032:analysis; D010627:Phenethylamines / Q000494:pharmacology*; D012313:RNA / Q000032:analysis; D013552:Swine / Q000378:metabolism*
D000318:Adrenergic beta-Agonists; D009124:Muscle Proteins; D010627:Phenethylamines; C060897:ractopamine; D012313:RNA; D004247:DNA; D002403:Cathepsins; D010447:Peptide Hydrolases